GO:0018601 4-nitrophenol 2-monooxygenase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0018601 defines the molecular function that catalyzes the reaction 4-nitrophenol + H+ + NADH + O2 = 4-nitrocatechol + H2O + NAD+.
• This activity is a monooxygenase reaction that inserts one oxygen atom into the aromatic ring of 4-nitrophenol, producing 4-nitrocatechol.
• The reaction requires NADH as an electron donor and molecular oxygen as a co-substrate, linking it to cellular redox and detoxification pathways.
• Cytochrome P450 enzymes, especially CYP2E1, are known to metabolize nitrophenol and other xenobiotics, providing a mechanistic context for this activity.
• Studying this activity helps researchers understand xenobiotic metabolism, oxidative stress, and environmental toxicology.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal testing of candidate genes involved in this activity.
Description
GO:0018601, 4-nitrophenol 2-monooxygenase activity, is a molecular function that catalyzes the conversion of 4-nitrophenol to 4-nitrocatechol with the consumption of NADH and O2. This reaction is a classic example of aromatic hydroxylation, a key step in the metabolism of nitroaromatic compounds, which are common environmental pollutants and industrial intermediates. Understanding this activity is important for researchers in toxicology, microbiology, and drug metabolism because it represents a route for detoxification or activation of xenobiotics. The enzyme responsible for this activity belongs to the monooxygenase family, which typically uses a heme or flavin cofactor to activate molecular oxygen. In mammalian systems, cytochrome P450 enzymes, particularly CYP2E1, are known to oxidize small aromatic molecules and are implicated in alcohol and xenobiotic metabolism. Therefore, GO:0018601 provides a functional annotation that connects gene products to a specific biochemical transformation with relevance to human health and environmental science.
4-nitrophenol 2-monooxygenase activity At A Glance
| GO ID | GO:0018601 |
|---|---|
| GO term | 4-nitrophenol 2-monooxygenase activity |
| Ontology | molecular_function |
| Synonym | 4-nitrophenol-2-hydroxylase activity; 4-nitrophenol hydroxylase activity; 4-nitrophenol,NADH:oxygen oxidoreductase (2-hydroxylating) |
| Major function | Catalyzes the hydroxylation of 4-nitrophenol to 4-nitrocatechol using NADH and O2 |
| Reaction | 4-nitrophenol + H+ + NADH + O2 = 4-nitrocatechol + H2O + NAD+ |
| Cofactors | NADH (electron donor), molecular oxygen (co-substrate) |
| Related enzymes | Cytochrome P450 monooxygenases, especially CYP2E1 |
| Research relevance | Xenobiotic metabolism, detoxification, oxidative stress, environmental toxicology |
What Is GO:0018601?
4-nitrophenol 2-monooxygenase activity (GO:0018601) is defined as the catalysis of the reaction: 4-nitrophenol + H+ + NADH + O2 = 4-nitrocatechol + H2O + NAD+. In this reaction, one molecule of 4-nitrophenol is hydroxylated at the 2-position to form 4-nitrocatechol, while NADH is oxidized to NAD+ and molecular oxygen is reduced to water. This is a monooxygenase-type reaction because one atom of oxygen from O2 is incorporated into the substrate, and the other is reduced to water.
Why Is 4-nitrophenol 2-monooxygenase activity Important in Cell Biology?
GO:0018601 is important because it describes a specific enzymatic step in the metabolism of nitroaromatic compounds, which are widespread environmental contaminants and industrial chemicals. The ability to hydroxylate 4-nitrophenol to 4-nitrocatechol can influence the toxicity, persistence, and bioavailability of these compounds. In mammals, cytochrome P450 enzymes such as CYP2E1 are known to metabolize a range of small molecules and are implicated in alcohol-induced oxidative stress and liver disease. Therefore, understanding this activity can inform studies on detoxification pathways, drug metabolism, and the health effects of environmental exposures.
• Provides a biochemical route for the degradation or transformation of 4-nitrophenol, a priority pollutant.
• Links to cytochrome P450-mediated xenobiotic metabolism, particularly CYP2E1.
• Relevant to oxidative stress because the reaction consumes NADH and O2 and can generate reactive intermediates.
• Helps researchers interpret toxicokinetic data for nitroaromatic compounds.
• Serves as a model reaction for studying aromatic hydroxylation mechanisms.
• Can be used as a functional marker in environmental microbiology and bioremediation studies.
• Connects to human diseases such as alcoholic liver disease where CYP2E1 activity is altered.
• Supports the development of enzyme inhibitors or probes for monooxygenase activity.
What Happens During 4-nitrophenol 2-monooxygenase activity?
Substrate binding and oxygen activation
In simple terms: The enzyme grabs 4-nitrophenol and oxygen, then activates the oxygen to attack the ring.
The reaction begins with the binding of 4-nitrophenol and molecular oxygen to the active site of the monooxygenase. In cytochrome P450 enzymes, the heme iron is reduced and binds O2, forming a reactive iron-oxo species that can hydroxylate aromatic substrates. This step requires NADH as an electron donor, which is oxidized to NAD+.
Hydroxylation at the 2-position
In simple terms: One oxygen atom is inserted next to the nitro group on the ring.
The activated oxygen species inserts one oxygen atom into the aromatic ring of 4-nitrophenol at the carbon adjacent to the nitro group, yielding 4-nitrocatechol. This regioselective hydroxylation is characteristic of the 2-monooxygenase activity defined by GO:0018601. The other oxygen atom from O2 is reduced to water.
Product release and NAD+ regeneration
In simple terms: The new product leaves, and the used electron carrier is recycled.
After hydroxylation, 4-nitrocatechol is released from the active site. The NADH consumed in the reaction is converted to NAD+, which can be regenerated by cellular metabolism. This step completes the catalytic cycle and allows the enzyme to turnover multiple substrate molecules.
Cellular context and detoxification
In simple terms: This reaction helps the cell process a harmful chemical into a more excretable form.
In cells, this activity is part of xenobiotic metabolism, where lipophilic compounds are converted to more water-soluble metabolites for excretion. Cytochrome P450 enzymes, including CYP2E1, are known to metabolize nitrophenol and related compounds, and their expression can be induced by alcohol or other xenobiotics. The resulting catechol can undergo further conjugation or oxidation.
Key Genes Involved in GO:0018601 4-nitrophenol 2-monooxygenase activity
The following genes and proteins are associated with monooxygenase activity, xenobiotic metabolism, or related redox processes that contextualize GO:0018601.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CYP2E1 | Cytochrome P450 enzyme that metabolizes small molecules and contributes to oxidative stress | Model for studying xenobiotic metabolism and alcohol-induced liver injury |
| CYP2A5 | Cytochrome P450 enzyme involved in alcohol and xenobiotic metabolism | Studied in alcoholic liver disease and carcinogen activation |
| ALDH2 | Aldehyde dehydrogenase that detoxifies acetaldehyde | Linked to alcohol metabolism and liver disease |
| ATGL | Adipose triglyceride lipase involved in lipid metabolism | Studied in alcohol-associated liver disease and AMPK signaling |
| AMPK | Energy sensor kinase that regulates lipid metabolism | Target in metabolic and liver disease research |
| Nrf2 | Transcription factor that regulates antioxidant defense | Protects against CYP2E1-mediated toxicity |
| CYP2E1 inhibitors | Small molecules that modulate CYP2E1 activity | Potential therapeutics for obesity and inflammation |
| Gut microbiota | Microbial community that influences xenobiotic metabolism | Studied in alcohol-associated liver disease |
| Bibenzyls | Plant-derived compounds with hepatoprotective effects | Modulate AMPK/ATGL and CYP2E1 pathways |
| 4-Methyl-5-acetylthiazole | Novel CYP2E1 inhibitor | Alleviates obesity via adipose inflammation and mitochondrial function |
| Cytochrome P450 (general) | Superfamily of monooxygenases that metabolize xenobiotics | Central to drug metabolism and toxicology |
| NADH | Electron donor for monooxygenase reactions | Cofactor in redox reactions and energy metabolism |
| O2 | Co-substrate for monooxygenase reactions | Required for oxidative metabolism |
| 4-Nitrophenol | Substrate for GO:0018601 | Environmental pollutant and model compound |
| 4-Nitrocatechol | Product of GO:0018601 | Metabolite for further degradation or excretion |
| CYP2E1 in sheep liver | Characterized enzyme activity in animal models | Comparative studies of P450 isoenzymes |
| CYP2E1 in placenta | Detoxification and metabolic role in pregnancy | Toxicokinetic studies in reproductive toxicology |
How Is 4-nitrophenol 2-monooxygenase activity Regulated?
The expression and activity of cytochrome P450 enzymes, including those that may catalyze 4-nitrophenol 2-monooxygenase activity, are regulated at multiple levels. CYP2E1 is induced by ethanol and other small molecules, and its activity can be modulated by oxidative stress and inflammatory signals. The Nrf2 pathway plays a protective role against CYP2E1-mediated toxicity by upregulating antioxidant defenses. Additionally, metabolic sensors such as AMPK can influence lipid metabolism and indirectly affect xenobiotic pathways. These regulatory mechanisms ensure that monooxygenase activity is adjusted to cellular redox status and exposure to xenobiotics.
4-nitrophenol 2-monooxygenase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CYP2E1 | Alcoholic liver disease, oxidative stress | CYP2E1 knockout mice or hepatocyte cell lines with point mutations |
| CYP2E1 | Obesity and adipose inflammation | Adipocyte-specific overexpression or knockout models |
| CYP2A5 | Alcoholic liver disease | Liver-specific knockout or knock-in models |
| ALDH2 | Alcohol metabolism disorders | ALDH2 point mutation knock-in mice |
| Nrf2 | Antioxidant defense against CYP2E1 toxicity | Nrf2 knockout or overexpression cell models |
Alcoholic Liver Disease
CYP2E1, a cytochrome P450 enzyme known to metabolize nitrophenol and other small molecules, is induced by alcohol and contributes to oxidative stress and liver injury. The 4-nitrophenol 2-monooxygenase activity represents a model for CYP2E1-mediated hydroxylation, and its dysregulation may exacerbate alcohol-associated liver disease. Studies have shown that compounds from Dendrobium huoshanense can attenuate alcohol-associated liver disease via modulation of CYP2E1 and other pathways.
Obesity and Metabolic Inflammation
A novel CYP2E1 inhibitor, 4-methyl-5-acetylthiazole, alleviates obesity by modulating adipose inflammation and mitochondrial dysfunction. This suggests that monooxygenase activities, including those related to 4-nitrophenol metabolism, may influence metabolic disease. Targeting such activities could provide therapeutic benefits in obesity and related disorders.
Alcohol-Related Cancers
Molecular mechanisms linking alcohol to gastric and colon cancer involve CYP2E1 and other enzymes that metabolize xenobiotics and generate reactive oxygen species. The 4-nitrophenol 2-monooxygenase activity is part of this broader metabolic network, and its study may help elucidate carcinogenic pathways.
From 4-nitrophenol 2-monooxygenase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CYP2E1 affect 4-nitrophenol 2-monooxygenase activity? | CYP2E1 knockout cell line or mouse model |
| Does a specific point mutation alter catalytic efficiency? | Point mutation knock-in via CRISPR in hepatocytes |
| Can a tagged version of the enzyme be used for localization studies? | Knock-in of fluorescent or affinity tag at the endogenous locus |
| Does overexpression of CYP2E1 increase 4-nitrocatechol production? | CYP2E1 overexpression stable cell line |
| Which genes regulate this activity in a whole-genome context? | CRISPR library screening with 4-nitrophenol as substrate |
| Can we identify novel regulators of monooxygenase activity? | CRISPR activation or interference library screening |
How to Study the 4-nitrophenol 2-monooxygenase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Spectrophotometric assay | Conversion of 4-nitrophenol to 4-nitrocatechol | Enzyme kinetics and inhibitor testing |
| HPLC or LC-MS | Substrate and product quantification | Metabolite profiling in cells or microsomes |
| RNA-seq | Gene expression changes | Identifying induced or repressed monooxygenases |
| qPCR | Specific gene expression | Validating candidate genes like CYP2E1 |
| Western blot | Protein levels | Confirming knockout or overexpression |
| CRISPR knockout screening | Gene essentiality or regulator identification | Genome-wide discovery of activity modulators |
| CRISPR activation screening | Gain-of-function phenotypes | Identifying activators of monooxygenase activity |
Enzymatic Assays
Direct measurement of 4-nitrophenol 2-monooxygenase activity can be performed using spectrophotometric or chromatographic methods that monitor the conversion of 4-nitrophenol to 4-nitrocatechol. These assays typically require NADH and O2 and can be adapted for high-throughput screening.
Gene Expression Analysis
RNA-seq or qPCR can be used to quantify the expression of candidate genes such as CYP2E1 under conditions that induce or repress the activity. This helps link gene expression to enzymatic activity.
Proteomics and Metabolomics
Mass spectrometry-based proteomics can identify and quantify monooxygenase enzymes, while metabolomics can measure 4-nitrocatechol and related metabolites. These approaches provide a systems-level view of the pathway.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens can be combined with a phenotypic readout of 4-nitrophenol metabolism to identify genes that regulate this activity. This unbiased approach can uncover novel regulators.
How CRISPR Can Be Used to Study GO:0018601 4-nitrophenol 2-monooxygenase activity
Knockout
CRISPR knockout of candidate genes such as CYP2E1 can be used to test whether they are required for 4-nitrophenol 2-monooxygenase activity. Loss-of-function models help establish causality and can be validated by enzymatic assays.
Point Mutation
Introducing specific point mutations in the active site of a monooxygenase can reveal residues critical for substrate binding or catalysis. This approach is useful for structure-function studies of GO:0018601.
Knock-in
Knock-in of a tagged version of the enzyme (e.g., FLAG or GFP) allows for localization and interaction studies without altering endogenous regulation. This can be combined with activity assays to correlate localization with function.
Overexpression
Overexpression of a candidate monooxygenase in cell lines can increase the flux through the 4-nitrophenol hydroxylation pathway, enabling detailed kinetic and inhibitor studies.
How EDITGENE Supports 4-nitrophenol 2-monooxygenase activity Research
Researchers studying 4-nitrophenol 2-monooxygenase activity-related genes often need to determine whether a candidate gene is causally involved in the observed enzymatic reaction. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for 4-nitrophenol 2-monooxygenase activity research.
Frequently Asked Questions About 4-nitrophenol 2-monooxygenase activity
What is 4-nitrophenol 2-monooxygenase activity?
It is a molecular function defined by GO:0018601 that catalyzes the conversion of 4-nitrophenol to 4-nitrocatechol using NADH and O2.
What genes are involved in 4-nitrophenol 2-monooxygenase activity?
Cytochrome P450 genes, particularly CYP2E1, are known to metabolize nitrophenol and related compounds.
What is the reaction catalyzed by GO:0018601?
The reaction is: 4-nitrophenol + H+ + NADH + O2 = 4-nitrocatechol + H2O + NAD+.
Which cofactors are required for 4-nitrophenol 2-monooxygenase activity?
NADH as an electron donor and molecular oxygen as a co-substrate are required.
How is 4-nitrophenol 2-monooxygenase activity regulated?
It can be regulated by induction of cytochrome P450 enzymes, oxidative stress, and pathways such as Nrf2.
What diseases are associated with 4-nitrophenol 2-monooxygenase activity?
Alcoholic liver disease, obesity, and alcohol-related cancers have been linked to CYP2E1 and related monooxygenase activities.
How can I study 4-nitrophenol 2-monooxygenase activity in the lab?
Enzymatic assays, gene expression analysis, proteomics, and CRISPR screening are common approaches.
What CRISPR models are available for studying this activity?
Knockout, point mutation, knock-in, and overexpression models can be generated for candidate genes like CYP2E1.
Can I use CRISPR screening to find regulators of 4-nitrophenol 2-monooxygenase activity?
Yes, genome-wide knockout or activation screens can identify genes that modulate this activity.
Where can I get custom CRISPR services for monooxygenase research?
EDITGENE provides knockout, point mutation, knock-in, overexpression, and library screening services for monooxygenase-related genes.
Conclusion
GO:0018601, 4-nitrophenol 2-monooxygenase activity, represents a specific enzymatic function with broad relevance to xenobiotic metabolism, detoxification, and human disease. Understanding its mechanism and regulation can provide insights into conditions such as alcoholic liver disease and obesity. CRISPR-based models offer powerful tools to dissect the genetic basis of this activity and identify new therapeutic targets.
References
- 1. Yan C et al.. 2025. Bibenzyls from Dendrobium huoshanense attenuate alcohol-associated liver disease via AMPK/ATGL, CYP2E1/ALDH2, and gut microbiota modulation.. Phytomedicine 148:157324 PMID: 41016299
- 2. Anzenbacher P et al.. 2001. Cytochromes P450 and metabolism of xenobiotics.. Cell Mol Life Sci 58(5-6):737-47 PMID: 11437235
- 3. Leung TM et al.. 2017. Alcoholic Liver Disease: from CYP2E1 to CYP2A5.. Curr Mol Pharmacol 10(3):172-178 PMID: 26278389
- 4. Na HK et al.. 2017. Molecular Basis of Alcohol-Related Gastric and Colon Cancer.. Int J Mol Sci 18(6) PMID: 28538665
- 5. Qiu J et al.. 2026. A Novel CYP2E1 Inhibitor, 4-Methyl-5-Acetylthiazole (Q11), Alleviates Obesity Via Modulating Adipose Inflammation and Mitochondrial Dysfunction.. Adv Sci (Weinh) 13(10):e15315 PMID: 41420839
- 6. Cederbaum A. 2009. Nrf2 and antioxidant defense against CYP2E1 toxicity.. Expert Opin Drug Metab Toxicol 5(10):1223-44 PMID: 19671018
- 7. Gonzalez FJ. 2007. The 2006 Bernard B. Brodie Award Lecture. Cyp2e1.. Drug Metab Dispos 35(1):1-8 PMID: 17020953
- 8. Meakin AS et al.. 2023. Characterisation of cytochrome P450 isoenzyme activity in sheep liver and placental microsomes.. Placenta 131:82-89 PMID: 36527743
